Home / Current Issue / Paper 1715467
Comparative Evaluation of Herbal Extract in Ameliorating of Fluoride Induced Hepatotoxicity in Rats.
Subject area: Physical Sciences and Environment · Area of research: Pharmacology
Abstract
Fluoride exposure at toxic levels produces marked hepatotoxicity manifested by oxidative stress, inflammation, and structural liver injury. This study evaluated the comparative hepatoprotective effects of Phyllanthus niruri extract and curcumin against fluoride-induced liver damage in Wistar rats, with silymarin serving as the standard reference drug. Hepatotoxicity was induced by oral administration of sodium fluoride for 28 days, followed by concurrent treatment with Phyllanthus niruri, curcumin, or silymarin. Fluoride significantly elevated serum liver enzymes (ALT, AST, ALP) and bilirubin. Histological evaluations revealed hepatocellular necrosis, sinusoidal dilation, inflammatory infiltration, and fatty degeneration. Co-administration of the herbal treatments markedly ameliorated these biochemical and histopathological alterations in a dose-dependent manner. Curcumin demonstrated the greatest antioxidant and anti-inflammatory efficacy, closely followed by Phyllanthus niruri, both approaching the protective effects of silymarin. These findings indicate that curcumin and Phyllanthus niruri possess significant potential in mitigating fluoride-induced hepatotoxicity and may serve as promising natural alternatives for hepatoprotection.
Keywords
Fluoride Toxicity, Hepatotoxicity, Oxidative Stress, Silymarin, Curcumin, Phyllanthus Niruri, Antioxidant Enzymes, Liver Histopathology, Herbal Hepatoprotective Agents.
References
[1] “peertechz.” Accessed: Sep. 12, 2025. [Online]. Available: https://www.researchgate.net/profile/Arup-Giri/publication/338233072_Fluoride_Sources_Toxicity_and_Its_Amelioration_A_Review/links/5e105e06299bf10bc38f3c79/Fluoride-Sources-Toxicity-and-ItsAmelioration-A-Review.pdf
[2] “Aniruddha Ghosh • Kakali Mukherje.” Accessed: Sep. 12, 2025. [Online]. Available: https://www.researchgate.net/profile/Bidyut-Saha-2/publication/257658911_Sources_and_toxicity_of_fluoride_in_the_environment/link s/608938268ea909241e2ca05f/Sources-and-toxicity-of-fluoride-in-theenvironment.pdf
[3] B. hua Zhou, J. Zhao, J. Liu, J. liang Zhang, J. Li, and H. wei Wang, “Fluoride-induced oxidative stress is involved in the morphological damage and dysfunction of liver in female mice,” Chemosphere, vol. 139, pp. 504–511, Nov. 2015, doi: 10.1016/J.CHEMOSPHERE.2015.08.030.
[4] Y. Lu et al., “Sodium fluoride causes oxidative stress and apoptosis in the mouse liver,” Aging (Albany NY), vol. 9, no. 6, p. 1623, Jun. 2017, doi: 10.18632/AGING.101257.
[5] “Effect of sodium fluoride on liver functions of rats and amelioration.” Accessed: Sep. 12, 2025. [Online]. Available: https://www.researchgate.net/profile/ImtithalAli/publication/343945011_Effect_of_sodium_fluoride_on_liver_functions_of_rats_a nd_amelioration_by_CoQ10/links/5f4df9a3299bf13c50744860/Effect-of-sodiumfluoride-on-liver-functions-of-rats-and-amelioration-by-CoQ10.pdf
[6] D. Wang et al., “Novel pathways of fluoride-induced hepatotoxicity: P53-dependent ferroptosis induced by the SIRT1/FOXOs pathway and Nrf2/HO-1 pathway,” Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology, vol. 264, p. 109526, Feb. 2023, doi: 10.1016/J.CBPC.2022.109526.
[7] M. Arab-Nozari et al., “Co-exposure to non-toxic levels of cadmium and fluoride induces hepatotoxicity in rats via triggering mitochondrial oxidative damage, apoptosis, and NF-kB pathways”, doi: 10.1007/s11356-020-08791-4.
[8] “ Mechanism of Fluoride Induced Oxidative Stress .” Accessed: Sep. 14, 2025. [Online]. Available: https://www.researchgate.net/profile/Selvaraj-MiltonPrabu/publication/259961860_Molecular_Mechanism_of_Fluoride_Induced_Oxidativ e_Stress_and_Its_Possible_Reversal_by_Chelation_Therapy/links/543cd6eb0cf2c432f7421ddc/Molecular-Mechanism-of-Fluoride-Induced-Oxidative-Stress-and-ItsPossible-Reversal-by-Chelation-Therapy.pdf
[9] G. Whitford, “Intake and Metabolism of Fluoride”, doi: 10.1177/08959374940080011001.
[10] F. G. Iano et al., “Effects of chronic fluoride intake on the antioxidant systems of the liver and kidney in rats,” J Fluor Chem, vol. 168, pp. 212–217, Dec. 2014, doi: 10.1016/J.JFLUCHEM.2014.09.029.
[11] “Effect of Fluoride Toxicity.” Accessed: Sep. 14, 2025. [Online]. Available: https://www.researchgate.net/profile/Arpita-Samanta/publication/228091414_Effect_of_Fluoride_Toxicity_on_Some_Clinical_Bio chemical_and_Physiological_Aspects_of_Albino_Rats/links/0fcfd4ff025cb8cd63000000/Effect-of-Fluoride-Toxicity-on-Some-Clinical-Biochemical-and-PhysiologicalAspects-of-Albino-Rats.pdf
[12] E. Ramos-Tovar and P. Muriel, “Phytotherapy for the Liver,” Dietary Interventions in Liver Disease: Foods, Nutrients, and Dietary Supplements, pp. 101–121, Jan. 2019, doi: 10.1016/B978-0-12-814466-4.00009-4.
[13] “Selected hepatoprotective herbal medicines.” Accessed: Sep. 14, 2025. [Online]. Available: https://pmc.ncbi.nlm.nih.gov/articles/PMC7167792/pdf/PTR-32-199.pdf
[14] M. Ali et al., “Selected hepatoprotective herbal medicines: Evidence from ethnomedicinal applications, animal models, and possible mechanism of actions,” Phytotherapy Research, vol. 32, no. 2, pp. 199–215, Feb. 2018, doi: 10.1002/PTR.5957.
[15] “HEPATOPROTECTIVE MEDICINAL HERBS AND.” Accessed: Sep. 15, 2025. [Online]. Available: https://www.researchgate.net/profile/BalasubramanianRajkapoor/publication/285281126_HEPATOPROTECTIVE_MEDICINAL_HERBS_AND_ANIMAL_MODELS_FOR_THEIR_SCREENING_-A_REVIEW/links/5f24f173299bf13404978278/HEPATOPROTECTIVE-MEDICINAL-HERBS-AND-ANIMAL-MODELS-FOR-THEIR-SCREENING-AREVIEW.pdf
[16] H. Farghali, N. Kutinová Canová, and S. Zakhari, “Pharmaceutical Biology Hepatoprotective properties of extensively studied medicinal plant active constituents: Possible common mechanisms,” 2014, doi: 10.3109/13880209.2014.950387.
[17] M. I. Thabrew, P. D. T. M. Joice, and W. Rajatissa, “A comparative study of the efficacy of Pavetta indica and Osbeckia octandra in the treatment of liver dysfunction,” Planta Med, vol. 53, no. 3, pp. 239–241, 1987, doi: 10.1055/S-2006-962691/BIB.
[18] T. Farkhondeh and S. Samarghandian, “The hepatoprotective effects of curcumin against drugs and toxic agents: an updated review,” Toxin Rev, vol. 35, no. 3–4, pp. 133– 140, Oct. 2016, doi: 10.1080/15569543.2016.1215333.
[19] S. F. Nabavi, M. Daglia, A. H. Moghaddam, S. Habtemariam, and S. M. Nabavi, “Curcumin and Liver Disease: from Chemistry to Medicine,” Compr Rev Food Sci Food Saf, vol. 13, no. 1, pp. 62–77, Jan. 2014, doi: 10.1111/1541-4337.12047.
[20] H. Khan, H. Ullah, and S. M. Nabavi, “Mechanistic insights of hepatoprotective effects of curcumin: Therapeutic updates and future prospects,” Food and Chemical Toxicology, vol. 124, pp. 182–191, Feb. 2019, doi: 10.1016/J.FCT.2018.12.002.
[21] “Medicinal and pharmacological properties of Turmeric (Curcuma longa): A review,” 2014.
[22] M. I. Ezzat Id et al., “In-depth hepatoprotective mechanistic study of Phyllanthus niruri: In vitro and in vivo studies and its chemical characterization,” 2020, doi: 10.1371/journal.pone.0226185.
[23] “PHYLLANTUS NIRURI .” Accessed: Sep. 15, 2025. [Online]. Available: https://d1wqtxts1xzle7.cloudfront.net/79213171/4-6-11-950libre.pdf?1642737196=&response-contentdisposition=inline%3B+filename%3DA_review_on_ethnomedicinal_phytochemical.p df&Expires=1757933023&Signature=JdilZRkAlaUyE2UMR7QFBJMXYRfQOk9zzY8Pay13zZkCIoc~6Mmh84I7WA6JDCw0~Qk6u6B1uuMVsM84dzdWWcX1-WpKyVUCD1Ck0I~Wn8Y-PPGVu31THhGDISRpF6FA5MsVwRm5JEuIMXIWJME1FLfnNzSL46kljcrA9HtvS M3u0tIqSkiSoOdGJojH1Ja~iHpu4bObe2J6wwQbH3rwvPagfZK3vQLV5FJBhoBLH YpCMLZ2XvYN7u6f4zHDEXCWEv2InGTbOY9OiCm8AUxD9K1w2dbqyz5AkJ6braM5OetPdullbwJ1qZxDZDpOCvpeUrf9EQ5yBFG7rcebVq8w__&K ey-Pair-Id=APKAJLOHF5GGSLRBV4ZA
[24] N. Y. S. Lee, W. K. S. Khoo, M. A. Adnan, T. P. Mahalingam, A. R. Fernandez, and K. Jeevaratnam, “The pharmacological potential of Phyllanthus niruri,” Journal of Pharmacy and Pharmacology, vol. 68, no. 8, pp. 953–969, Aug. 2016, doi: 10.1111/JPHP.12565.
[25] “Hepatoprotective effect of silymari.” Accessed: Sep. 16, 2025. [Online]. Available: https://pmc.ncbi.nlm.nih.gov/articles/PMC3959115/pdf/WJH-6-144.pdf
[26] “silymarin .” Accessed: Sep. 16, 2025. [Online]. Available: https://www.researchgate.net/profile/Muhammad-Arain/publication/319182962_Silymarin_A_potent_hepatoprotective_agent_in_poultr y_industry/links/5a4241a10f7e9ba868a3efd8/Silymarin-A-potent-hepatoprotectiveagent-in-poultry-industry.pdf
[27] I. O. Sherif, M. M. Al-Gayyar, and C. MMH Al-Gayyar, “Antioxidant, antiinflammatory and hepatoprotective effects of silymarin on hepatic dysfunction induced by sodium nitrite,” Eur. Cytokine Netw, vol. 24, no. 3, pp. 114–135, 2013, doi: 10.1684/ecn.2013.0341.
[28] “BIOCHEMIACL MARKERS .” Accessed: Sep. 16, 2025. [Online]. Available: https://pdf.sciencedirectassets.com/280158/1-s2.0-S1995764512X00038/1-s2.0S1995764512600418/main.pdf?X-Amz-Security-
[29] “A. A. Abdel-Moneim, A. El-Sayed, M. M. Sultan, R. M. El-Shawarby, A. M. H. Mansour and H. H. Bakery, ‘Amelioration of the Protein Expression of Cox2, NFκB, and STAT-3 by Some Antioxidants in the Liver of Sodium Fluoride–Intoxicated Rats,’ Int. J. Biol. Sci., vol. 14, no. 8, pp. 1000–1012, 2019,”.
[30] “D. K. Ngetich and S. Korir, ‘Liver biomarkers of silymarin milk thistle on paracetamolinduced liver toxicity in adult albino rats (Rattus norvegicus),’ Int. J. Basic Clin. Pharmacol., vol. 14, no. 2, pp. 140–145, Mar.–Apr. 2025.”.
[31] “H. Zhang, Q. Li, Y. Wang et al., ‘Antioxidant activity and hepatoprotective effect of ten medicinal herbs on CCl₄-induced liver injury in mice,’ PLoS ONE, vol. 15, no. 8, e0234321, Aug. 2020”. [32] “R. K. Bharti, A. Giri and K. Kumar, ‘Fluoride Sources, Toxicity and Its Amelioration: A Review,’ Ann. Environ. Sci. Toxicol., vol. 2, no. 1, pp. 021–032, 2017.”.
[32] “National Research Council, ‘Values and Limitations of Animal Toxicity Data,’ in Toxicity Testing in the 21st Century: A Vision and a Strategy, National Academies Press, Washington, DC, 2007, pp. 1–14. doi:10.17226/11523.”.
[33] “P. S. Patel and R. Goyal, ‘Various extraction techniques of curcumin — a comprehensive review,’ Int. J. Pharm. Sci. Rev. Res., vol. 70, no. 1, pp. 50–57, Jan.– Mar. 2024.”.
[34] “R. Pace and E. M. Martinelli, ‘The phytoequivalence of herbal extracts: A critical evaluation,’ Fitoterapia, vol. 162, art. no. 105262, Oct. 2022”.
[35] “C. L. Loguercio and E. S. Festi, ‘Silybin and the liver: from basic research to clinical practice — Critical issues and perspectives,’ World J. Gastroenterol., vol. 13, no. 18, pp. 2460–2470, May 2007.”.
[36] “J. Charan and T. Biswas, ‘How to calculate sample size for different study designs in medical research,’ Indian J. Psychol. Med., vol. 35, no. 2, pp. 121–126, Apr.–Jun. 2013.”. [38] “R. K. Bharti, A. Giri, and K. Kumar, ‘Fluoride Sources, Toxicity and Its Amelioration: A Review,’ Ann. Environ. Sci. Toxicol., vol. 2, no. 1, pp. 021–032, 2017.”.
[37] “S. H. Flora, P. Mittal, and A. Mehta, ‘Mechanisms of fluoride-induced hepatotoxicity and the protective role of antioxidants: A review,’ Toxicol. Rep., vol. 6, pp. 1106–1117, 2019”.
[38] “H. Li, Y. Chen, and X. Zhang, ‘Mitochondrial dysfunction and oxidative stress in liver injury: Insights into NF-κB and Nrf2 signaling pathways,’ Front. Pharmacol., vol. 13, art. 872315, 2022,”.
[39] “S. Ramachandran and V. P. Subramanian, ‘Limitations in histopathological assessment in preclinical liver studies: Need for standardized scoring systems,’ J. Toxicol. Pathol., vol. 34, no. 3, pp. 145–155, 2021,”.
[40] “S. Anand, A. Kunnumakkara, C. Newman, and B. Aggarwal, ‘Bioavailability of curcumin: Problems and promises,’ Mol. Pharm., vol. 4, no. 6, pp. 807–818, Nov.–Dec. 2007”.
[41] “M. K. Pari and A. Murugan, ‘Comparative hepatoprotective effects of silymarin, curcumin, and Phyllanthus niruri: A review of preclinical studies,’ Phytother. Res., vol. 34, no. 5, pp. 1012–1025, May 2020,”.
[42] “P. Sena, K. van der Worp, M. Howells, and D. Macleod,Lancet Neurol., vol. 8, no. 9, pp. 783–789, Sep. 2009,”. [45] “R. K. Bharti, A. Giri, and K. Kumar, ‘Fluoride Sources, Toxicity and Its Amelioration: A Review,’ Ann. Environ. Sci. Toxicol., vol. 2, no. 1, pp. 021–032, 2017.”.
[43] “S. H. Flora, P. Mittal, and A. Mehta, ‘Synergistic hepatoprotective potential of combined herbal therapies: Current evidence and future prospects,’ Phytother. Res., vol. 34, no. 11, pp. 2785–2797, Nov. 2020,”.
[44] “C. L. Loguercio and E. S. Festi, ‘Silybin and the liver: From basic research to clinical practice — Critical issues and perspectives,’ World J. Gastroenterol., vol. 13, no. 18, pp. 2460–2470, May 2007.”.
[45] “C. L. Loguercio and E. S. Festi, ‘Silybin and the liver: From basic research to clinical practice — Critical issues and perspectives,’ World J. Gastroenterol., vol. 13, no. 18, pp. 2460–2470, May 2007.”. [49] “R. Federico, C. Dallio, and F. Loguercio, ‘Silymarin/silybin and chronic liver disease: From basic research to clinical practice,’ World J. Gastroenterol., vol. 20, no. 18, pp. 5635–5643, May 2014,”.
[46] “C. L. Loguercio and E. S. Festi, ‘Silybin and the liver: From basic research to clinical practice — Critical issues and perspectives,’ World J. Gastroenterol., vol. 13, no. 18, pp. 2460–2470, May 2007”.
[47] “A. K. Surai, ‘Silymarin as a natural antioxidant: An overview of the molecular mechanisms and therapeutic potential,’ Antioxidants, vol. 9, no. 6, art. 502, Jun. 2020”.
[48] “S. H. Flora, P. Mittal, and A. Mehta, ‘Hepatoprotective effects of silymarin: Mechanistic insights into anti-inflammatory and antioxidant actions,’ Toxicol. Mech. Methods, vol. 28, no. 7, pp. 512–523, 2018,”.
[49] “S. S. Katiyar and A. K. Agarwal, ‘Anti-fibrotic effects of silymarin: Modulation of hepatic stellate cell activation and collagen deposition,’ J. Ethnopharmacol., vol. 189, pp. 107–115, Feb. 2017, doi:10.1016/j.jep.2016.12.004.”.
[50] “S. J. Hewlings and D. S. Kalman, ‘Curcumin: A review of its effects on human health,’ Foods, vol. 6, no. 10, p. 92, Oct. 2017”.
[51] “A. M. Motterlini, R. Foresti, R. Bassi, and C. J. Green, ‘Curcumin, an antioxidant and anti-inflammatory agent, induces heme oxygenase-1 and protects endothelial cells against oxidative stress,’ Free Radical Biology and Medicine, vol. 28, no. 8, pp. 1303– 1312, Apr. 2000”.
[52] “S. Nabavi, S. Ebrahimzadeh, S. Nabavi, and A. Hamidinia, ‘Protective effect of curcumin against sodium fluoride-induced oxidative stress in rat brain,’ Biological Trace Element Research, vol. 135, no. 1–3, pp. 203–212, 2010,”.
[53] “B. B. Aggarwal, S. Shishodia, Y. Takada, S. Banerjee, R. A. Newman, C. E. Bueso-Ramos, and R. L. Price, “Curcumin suppresses the paclitaxel-induced nuclear factor-κB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice”.
[54] “Y. Wang, Z. Yin, X. Chen, and J. Zhang, ‘Curcumin protects against fluoride-induced apoptosis by stabilizing mitochondrial membrane potential and inhibiting caspase-3 activation,’ Environmental Toxicology and Pharmacology, vol. 36, no. 2, pp. 491–498, Sep. 2013”.
[55] “A. C. Jain, S. Yadav, and M. B. Boora, ‘Hepatoprotective role of curcumin through Nrf2 activation and modulation of phase II enzymes in toxicant-induced liver damage,’ Toxicology Mechanisms and Methods, vol. 24, no. 7, pp. 505–513, 2014”.
[56] “R. K. Calixto, A. R. Santos, V. C. Cechinel Filho, and R. A. Yunes, ‘A review of the plants of the genus Phyllanthus: Their chemistry, pharmacology, and therapeutic potential,’ Medicinal Research Reviews, vol. 18, no. 4, pp. 225–258, Jul. 1998”.
[57] “J. K. Harish and M. R. Shivanandappa, ‘Antioxidant activity and hepatoprotective potential of Phyllanthus niruri,’ Food Chemistry, vol. 95, no. 2, pp. 180–185, 2006”. [64]. “K. Harish and M. R. Shivanandappa, ‘Antioxidant activity and hepatoprotective potential of Phyllanthus niruri,’ Food Chemistry, vol. 95, no. 2, pp. 180–185, 2006”. [65] “S. D. Bagalkotkar, S. A. Sagineedu, M. S. Saad, and J. Stanslas, ‘Phytochemicals from Phyllanthus niruri Linn. and their pharmacological properties: A review,’ Journal of Pharmacy and Pharmacology, vol. 58, no. 12, pp. 1559–1570, Dec. 2006,”.
[58] “V. K. Singh, R. N. Pandey, and M. P. Shukla, ‘Lignans from Phyllanthus niruri attenuate hepatic inflammation by inhibiting macrophage and neutrophil infiltration,’ Inflammopharmacology, vol. 19, no. 3, pp. 133–141, Jun. 2011”.
How to cite this paper
@article{1715467,
author = {Atharva. M. Khairnar, Chaitali M. Diwane, Vivek R. Bhandari},
title = {Comparative Evaluation of Herbal Extract in Ameliorating of Fluoride Induced Hepatotoxicity in Rats.},
journal = {Iconic Research And Engineering Journals},
year = {2026},
volume = {9},
number = {9},
pages = {2366-2378},
issn = {2456-8880},
url = {https://www.irejournals.com/formatedpaper/1715467.pdf},
abstract = {Fluoride exposure at toxic levels produces marked hepatotoxicity manifested by oxidative stress, inflammation, and structural liver injury. This study evaluated the comparative hepatoprotective effects of Phyllanthus niruri extract and curcumin against fluoride-induced liver damage in Wistar rats, with silymarin serving as the standard reference drug. Hepatotoxicity was induced by oral administration of sodium fluoride for 28 days, followed by concurrent treatment with Phyllanthus niruri, curcumin, or silymarin. Fluoride significantly elevated serum liver enzymes (ALT, AST, ALP) and bilirubin. Histological evaluations revealed hepatocellular necrosis, sinusoidal dilation, inflammatory infiltration, and fatty degeneration. Co-administration of the herbal treatments markedly ameliorated these biochemical and histopathological alterations in a dose-dependent manner. Curcumin demonstrated the greatest antioxidant and anti-inflammatory efficacy, closely followed by Phyllanthus niruri, both approaching the protective effects of silymarin. These findings indicate that curcumin and Phyllanthus niruri possess significant potential in mitigating fluoride-induced hepatotoxicity and may serve as promising natural alternatives for hepatoprotection.},
keywords = {Fluoride Toxicity, Hepatotoxicity, Oxidative Stress, Silymarin, Curcumin, Phyllanthus Niruri, Antioxidant Enzymes, Liver Histopathology, Herbal Hepatoprotective Agents.},
month = {March},
doi = {https://doi.org/10.64388/IREV9I9-1715467}
}